Shusuke Tsuzuki

29PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersRadiation therapyPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Surgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 15, 2026
Recurrence and timing of conversion to radical nephroureterectomy after endoscopic laser ablation for upper tract urothelial carcinoma: a multicenter Japanese study.

|Apr 21, 2026
Prognostic impact of large cribriform architecture and intraductal carcinoma of the prostate in diagnostic biopsies of mCSPC receiving ARPI-based therapy.

|Apr 20, 2026
Author's reply to 'Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy'.

|Mar 12, 2026
Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysis.

Kazuki Nishimura, Kensuke Hirosuna, Heima Niigawa

|Feb 03, 2026
Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxel.

Taizo Uchimoto, Kensuke Hirosuna, Heima Niigawa

|Jan 25, 2026
Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomy.

Miyaka Umemori, Shun Sato, Fumihiko Urabe

Pageof 5

Frequent Collaborators

23 joint publications

Fumihiko Urabe

18 joint publications

Takahiro Kimura

14 joint publications

Jun Miki

8 joint publications

Takafumi Yanagisawa